Image credit: Michael Swan

Q&A: What’s Next for Cannabis in Israel?

On the eve of the Israeli election, Cannabis Wire editor Alyson Martin spoke with Israel Cannabis (iCAN) founder Saul Kaye about why the industry is closely watching the US.

Israel
New York

Leading New York Lawmaker “Optimistic” About Cannabis Legalization’s Chances in 2020

New York Senator Liz Krueger, speaking at a cannabis event on Tuesday evening, also shared where the state’s legalization effort this year went wrong.

Newsletter

More FDA and FTC warnings to CBD sellers • Horizons ETFs: cannabis has lost its “buzz” • & more…

An excerpt from the October 23 edition of the Cannabis Wire Daily newsletter.

Lobbying

The Incredibly Large Lobbying Footprint of Greenwich Biosciences

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states.